Showing results (511-520 of 545) with videos related to

Sort By:
Pageof 55
European Urology Focus|August 3, 2023
Impact of the Standardization of Penile Cancer Care on the Quality of Care, Outcomes, and Academic-driven Centralization in a Single eUROGEN Referral CenterAlessio Pecoraro, Laura Elst, Eduard Roussel, et al.
World Journal of Urology|March 30, 2020
Correction to: Metastasectomy for visceral and skeletal oligorecurrent prostate cancerAntonino Battaglia, Gaëtan Devos, Karel Decaestecker, et al.
JMIR Research Protocols|December 15, 2018
Benefits of Elective Para-Aortic Radiotherapy for pN1 Prostate Cancer Using Arc Therapy (Intensity-Modulated or Volumetric Modulated Arc Therapy): Protocol for a Nonrandomized Phase II TrialCédric Draulans, Steven Joniau, Valérie Fonteyne, et al.
European Urology|September 27, 2022
ARNEO: A Randomized Phase II Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate CancerGaëtan Devos, Lorenzo Tosco, Marcella Baldewijns, et al.
Iscience|June 15, 2026
Tinnitus and tinnitus disorder: Genetic, neurobiological, and clinical differentiationDirk De Ridder, Tobias Kleinjung, Jae-Jin Song, et al.
European Urology Oncology|August 15, 2019
Validation of the Decipher Test for Predicting Distant Metastatic Recurrence in Men with High-risk Nonmetastatic Prostate Cancer 10 Years After SurgeryThomas Van den Broeck, Lisa Moris, Thomas Gevaert, et al.
European Urology Oncology|July 13, 2024
Effect of Radical Prostatectomy on Survival for Men with High-risk Nonmetastatic Prostate Cancer Features Selected According to STAMPEDE Criteria: An EMPaCT StudyDaimantas Milonas, Alexander Giesen, Annouschka Laenen, et al.
European Urology Oncology|December 30, 2025
Final Results of the Randomised Phase 2 Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer (ARNEO)Alexander Giesen, Gaëtan Devos, Lorenzo Tosco, et al.
European Urology Open Science|August 18, 2025
Prognostic Stratification of pN1 Prostate Cancer After Radical Prostatectomy: A Competing Risk Analysis from a Multi-institutional CohortAlexander Giesen, Daimantas Milonas, Annouschka Laenen, et al.
European Urology Open Science|July 23, 2024
Risk of Cancer-related Death for Men with Biopsy Grade Group 1 Prostate Cancer and High-risk Features: A European Multi-institutional StudyDaimantas Milonas, Alexander Giesen, Tim Muilwijk, et al.
Pageof 55